Aripiprazole Tablet
Product Images NDC 50090-6403

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 50090-6403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Aripiprazole Fig1)

The text describes the effect of different drugs on Aripiprazole, indicating the fold change and 90% confidence interval. Several inhibitors and inducers of enzymes such as CYP3AA and CYP206 are mentioned, along with others like valproate and lorazepam. The text also mentions the change relative to the reference without the interacting drug.*

FDA Label Image

Figure (Aripiprazole Fig2)

This appears to be a chart or table showing the effect of various drugs on aripiprazole metabolism, including inhibitors and inducers of specific enzymes and other interacting drugs. It also includes data measurements like AuC, Cmax, and fold change with corresponding confidence intervals.*

FDA Label Image

Figure (Aripiprazole Fig3)

FDA Label Image

Figure (Aripiprazole Fig4)

FDA Label Image

Figure (Aripiprazole Fig5)

FDA Label Image

Figure 6: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (schizophrenia Study 5) (Aripiprazole Fig6)

This is a graph of the Kaplan-Meier estimation showing the cumulative proportion of patients with relapse in schizophrenia study 5. The graph compares the proportion of patients who relapsed while taking Aripiprazole versus patients who were administered placebo. The X-axis denotes the number of days from randomization while the Y-axis shows proportion with relapse. The number of subjects at risk is also shown for both groups.*

FDA Label Image

Figure 9: Least Square Means Of Change From Baseline In Ygtss Tts By Week (tourette’s Disorder Study 1) (Aripiprazole Fig7)

The text describes a graph or chart that shows the change in YGTSS (Yale Global Tic Severity Scale) Total TIC Score over time, specifically from baseline to weeks of treatment, for a medication called aripiprazole. The graph compares low and high doses of the drug with a placebo. The data is presented as the least-squares mean change in the score.*

FDA Label Image

Aripiprazole Structure (Aripiprazole Str)

FDA Label Image

Label Image (Lbl500906403)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.